Beijing Wantai Biological Pharmacy Enterprise Co Ltd
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. research, develops, produces, and sells in vitro diagnostic reagents and instruments, and vaccines in China and internationally. It operates through Diagnostics Division and Vaccine Division segments. The company offers chemiluminescence detection, biochemical, hepatitis B core antibody detection, and HIV reagents; rapid urine tests for hepa… Read more
Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) - Total Liabilities
Latest total liabilities as of September 2025: CN¥2.10 Billion CNY
Based on the latest financial reports, Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) has total liabilities worth CN¥2.10 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Beijing Wantai Biological Pharmacy Enterprise Co Ltd - Total Liabilities Trend (2013–2024)
This chart illustrates how Beijing Wantai Biological Pharmacy Enterprise Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Competitors by Total Liabilities
The table below lists competitors of Beijing Wantai Biological Pharmacy Enterprise Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Acadian Asset Management Inc
NYSE:AAMI
|
USA | $593.00 Million |
|
Ryman Healthcare Limited
PINK:RHCGF
|
USA | $7.95 Billion |
|
Jereissati Participações S.A.
SA:IGTI11
|
Brazil | R$4.79 Billion |
|
Betsson AB (publ)
PINK:BTSNY
|
USA | $433.90 Million |
|
Borregaard ASA
PINK:BRRDF
|
USA | $397.62 Million |
|
Hakuhodo DY Holdings Inc
OTCGREY:HKUOF
|
USA | $484.89 Billion |
|
Jonjee Hi-tech Industrial and Commercial Holding Co Ltd
SHG:600872
|
China | CN¥2.20 Billion |
|
Betta Pharmaceuticals Co Ltd
SHE:300558
|
China | CN¥3.78 Billion |
Liability Composition Analysis (2013–2024)
This chart breaks down Beijing Wantai Biological Pharmacy Enterprise Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.26 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.17 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Beijing Wantai Biological Pharmacy Enterprise Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Beijing Wantai Biological Pharmacy Enterprise Co Ltd (2013–2024)
The table below shows the annual total liabilities of Beijing Wantai Biological Pharmacy Enterprise Co Ltd from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥2.24 Billion | -20.83% |
| 2023-12-31 | CN¥2.83 Billion | -22.74% |
| 2022-12-31 | CN¥3.66 Billion | +47.56% |
| 2021-12-31 | CN¥2.48 Billion | +168.98% |
| 2020-12-31 | CN¥923.29 Million | +58.05% |
| 2019-12-31 | CN¥584.19 Million | +31.50% |
| 2018-12-31 | CN¥444.24 Million | -41.30% |
| 2017-12-31 | CN¥756.80 Million | +52.96% |
| 2016-12-31 | CN¥494.76 Million | +30.57% |
| 2015-12-31 | CN¥378.93 Million | +68.27% |
| 2014-12-31 | CN¥225.19 Million | +0.12% |
| 2013-12-31 | CN¥224.92 Million | -- |